Φορτώνει......
ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer
BACKGROUNDS/AIMS: Graft survival after ABO-incompatible (ABOi) living donor liver transplantation (LDLT) has increased due to advances in desensitization methods. We analyzed early outcomes following ABOi LDLT using only rituximab without any additional desensitization methods in recipients with low...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Hepatobiliary Pancreat Surg |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Korean Association of Hepato-Biliary-Pancreatic Surgery
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728259/ https://ncbi.nlm.nih.gov/pubmed/31501808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2019.23.3.211 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|